BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

InDex Pharmaceuticals AB 

Scheeles väg 2

Stockholm    SE-171 77  Sweden
Phone: 46-8-50884730 Fax: 46-8-50884739


SEARCH JOBS


 Key Statistics


Email: info@indexpharmab.com
Ownership: Private

Web Site: InDex Pharmaceuticals AB
Employees:
Symbol: 
 



Industry
Pharmaceutical






 Company News
InDex Pharmaceuticals AB Closes $20 Million Financing Round, Welcomes NeoMed As New Shareholder 2/25/2014 10:09:13 AM    More...
InDex Pharmaceuticals AB Completes Patient Recruitment in P3 Ulcerative Colitis Study With Kappaproct 4/8/2013 11:35:35 AM    More...
InDex Pharmaceuticals AB Granted Japanese Patent for Novel Treatment of Steroid-Resistant Inflammation 10/24/2012 10:17:21 AM    More...
InDex Pharmaceuticals AB Strengthens IP Position for Kappaproct 9/4/2012 11:19:38 AM    More...
InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early 5/18/2009 8:56:11 AM    More...
The Day In Review: Sanofi-Aventis (France) (SASY.PA) Adds To Generics Business 3/27/2006 6:38:54 PM    More...
InDex Signs $35M Agreement With Serono For Inflammation 10/19/2005 5:10:10 PM    More...
Serono (SRA) And Swedish Biotech Company InDex Pharmaceuticals AB Sign Worldwide Agreement To Develop And Commercialize Novel Ulcerative Colitis Treatment 10/19/2005 5:10:07 PM    More...

//-->